BF Biosciences Limited (PSX:BFBIO)
139.13
+1.08 (0.78%)
At close: Jun 2, 2026
BF Biosciences Market Cap
BF Biosciences has a market cap or net worth of 12.29 billion as of June 2, 2026. Its market cap has decreased by -9.18% in one year.
Market Cap
12.29B
Enterprise Value
13.12B
Revenue
8.86B
Ranking
n/a
PE Ratio
20.77
Stock Price
139.13
Market Cap Chart
Since October 22, 2024, BF Biosciences's market cap has increased from 7.41B to 12.29B, an increase of 65.91%. That is a compound annual growth rate of 37.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 12.19B | -1.76% |
| Dec 31, 2025 | 12.41B | -40.17% |
| Dec 31, 2024 | 20.75B | 180.05% |
| Oct 22, 2024 | 7.41B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens (Pakistan) Engineering | 12.74B |
| Hum Network | 12.54B |
| Macter International | 12.37B |
| Zarea | 12.36B |
| Century Paper & Board Mills | 12.22B |
| MCB investment management | 12.16B |
| Pakistan Synthetics | 12.06B |
| Netsol Technologies | 11.60B |